Arkolith/Insider Trading/BRTX/Form 4

Silva Francisco

VP of Research and Development, DirectorBioRestorative Therapies, Inc. (BRTX) · full profile →Form 4 · filed Nov 4, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 3, 2022Grant(A)42K—$042K
Nov 3, 2022Disposed to issuer(D)42K—$00
Nov 3, 2022Grant(A)293K—$0293K
Nov 3, 2022Disposed to issuer(D)293K—$00

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001567619-22-019198) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML